So you can’t get FUROSCIX in a direct form without having engaged with us. We are going to make sure that the usage is appropriate and that the patients have a good experience. So we’ve had a lot of these in services. They’ve gone well. The reps, to be able to see their whole territory, it’s after we conduct all the in services, we’ll probably be on a four or five week cycle. So we haven’t even got to all of our doctors yet because these calls are taking one to two hours. But that’s what’s most important to us right now. So if you go back to the patient types, it is these patients that kind of have it in the queue, they all call them in and say, we have something for you now. And actually put them on drug there. So — and then obviously, patients coming in on sick visits, patients that are coming back after being discharged from the hospital and patients that they know are going to be in and out of the hospital or need IV treatment every month, a couple of days a month.
They’re going ahead in prescribing FUROSCIX those patients. So it’s kind of the patient type we thought maybe with the slight caveat that we didn’t quite expect the bolus of patients that the doctors had queued, ready to go when we walked in. But — so that’s where we are. I hope I answered — we answered your questions. Steve, I’ll let —
Stacy Ku: That’s very helpful. And just to confirm, before you had said in your prepared remarks, you said one to two hours for your services. And then you said 300 something is the number of clinics that you now service. Just to make sure since you — it sounds like you’re really taking the time to make sure. Is that correct?
John Tucker: So that’s not all the falls we have. We’re going to about 3,000 cycles. But to set up the in-service, you’re going to walk into the doctor’s office and schedule the in-service. Now we have had opportunities where we walked in and we drop right into an in-service. But typically, you want to schedule a line churn in surface because it’s not a minute call. Now these calls, we’ll start making more and more calls as the in-services start in servicing all the offices. But it’s really a key metric for us is these in surface. So we’ve done about 3,000 calls and over 300 in service to date.
Stacy Ku: Okay. Thank you for that clarification.
Operator: Thank you. Our next question is from Douglas Tsao with H.C. Wainwright. Please proceed with your question.
Douglas Tsao: Hi, good afternoon. And thanks for taking the questions. So John, maybe as a follow-up. And I guess when you think about in service, what is the key goal of that? And are you changing or potentially changing behavior for a way that physicians might or thought about using the product, but then they have the in-service and they have a better understanding of how to best deploy FUROSCIX.
John Tucker: So, I’ll let Steve answer that. I will say this, one thing that’s been interesting is that we always say it’s going to take a couple of calls to change a doctor’s behavior. We’re seeing doctors in immediately after or in service with the script. So a lot of them are waiting for this and are aware of it. But that’s one thing that I think we’ve seen. And again, I think it has to do with the depth of the in-service and the knowledge of the patients. And the fact that we’ve said it all along, they’ve used IV strength furosemide in their entire career. So this isn’t kind of a new molecular entity. But Steve, do you want to talk more about?
